Publications

1. Yilma T: The pathogenesis of influenza virus in the murine respiratory tract. Ph.D. Thesis, University of California, Davis, 1977.
2. Yilma T, McVicar JW, Breese SS Jr: Prelytic release of foot-and-mouth disease virus from cell culture by cytoplasmic bleb formation. J Cell Biol 75: 394a (VI082), 1977.
3. Yilma T, McVicar JW, Breese SS Jr: Prelytic release of foot-and-mouth disease virus in cytoplasmic blebs. J Gen Virol 41: 105-114, 1978.
4. Yilma T, Zee YC, Osebold JW: Immunofluorescence determination of the pathogenesis of infection with influenza virus in mice following exposure to aerosolized virus. J Infect Dis 139: 458-464, 1979.
5. Yilma T, Breese SS Jr: Morphogenesis: Assembly and release of bovine enterovirus. J Cell Biol 83: 457a (VC2705), 1979.
6. Yilma T, Breese SS Jr: Morphogenesis of the assembly and release of bovine enterovirus. J Gen Virol 49: 225-230, 1980.
7. Yilma T: Morphogenesis of vesiculation in foot-and-mouth disease. Am J Vet Res 41: 1537-1542, 1980.
8. Blackwell HJ, Yilma T: Localization of infectious foot-and-mouth disease virus in alveolar cells of the bovine mammary gland. Am J Vet Res 42: 770-773, 1980.
9. Yilma T, McGuire TC, Perryman LE: Preliminary characterization of equine interferons and their antiviral activities on bovine, ovine, and human cells. J Interferon Res 2: 363-370, 1982.
10. Yilma T, Perryman LE, McGuire TC: Deficiency of interferon-q, but not interferon-á in Arabian foals with severe combined immunodeficiency. J Immunol 129: 931-933, 1982.
11. Yilma T: Sensitivity of ovine choroid plexus cells to human and other animal interferons. J Gen Virol 64: 2013-2016, 1983.
12. Yilma T, Breeze RG, Leib SR: Greater sensitivity of caprine synovial membrane cells to human interferon-alpha than human or bovine cells. Am J Vet Res 45: 2094-2095, 1984.
13. Yilma T, Breeze RG, Ristow, S, Gorham J, Leib SR: The immune response of cattle and mice to the G glycoprotein of vesicular stomatitis virus. Proc Int Conf Vesicular Stomatitis, Mexico City, D.F., Mexico, 1: 608-622, 1984.
14. Huang SA, Yilma T, Wu T-Y: Correlation between virulence of vesicular stomatitis virus isolates and continued high titers during undiluted passage. Proc Int Conf Vesicular Stomatitis, Mexico City, D.F., Mexico, 1: 523-541, 1984.
15. Yilma T, Owens S, Adams DS: Preliminary characterization of a serum viral inhibitor in goats. Am J Vet Res 46: 2360-2362, 1985.
16. Davis WC, Yilma T, Perryman LE, McGuire TC: Perspectives on the application of monoclonal antibody and transfection technology in veterinary microbiology. Prog Vet Microbiol Immunol 1: 1-24, 1985.
17. Mackett M, Yilma T, Rose JK, Moss B: Vaccinia virus recombinants: Expression of VSV genes and protective immunization of mice and cattle. Science 227: 433-435, 1985.
18. Yilma T: Use of ovine and caprine cells to measure antiviral effects of interferon. Methods Enzymol 119: 551-558, 1985.
19. Yilma T: Induction of equine interferons. Methods Enzymol 119: 130-136,1985.
20. Yilma T, Breeze RG, Ristow S, Gorham J, Leib SR: Immune responses of cattle and mice to the G glycoprotein of vesicular stomatitis virus. Adv Exp Med Biol 150: 101-115, 1985.
21. Yilma T, Breeze RG: New technology for prevention and control of infectious bovine respiratory diseases. Vet Clin North Am 1(2): 419-439,1985.
22. Yilma T, Mackett M, Rose JK, Moss B: Vaccinia virus recombinants expressing vesicular stomatitis genes immunize mice and cattle. In: Quinnan GV ed. Vaccinia Viruses as Vectors for Vaccine Antigens. New York: Elsevier-North Holland, pp. 187-200, 1985.
23. Jones L, Ristow S, Yilma T, Moss B: Accidental vaccination of a human with a vaccinia virus recombinant expressing the nucleoprotein gene of vesicular stomatitis virus. Nature 319: 543, 1986.
24. Huang AS, Wu T, Yilma T, Lanman G: Characterization of virulent isolates of vesicular stomatitis virus in relation to interference by defective particles. Microbial Pathogenesis 1: 205-215, 1986.
25. Workman T, Shen D, Woodard L, Yilma T: An enzyme-linked immunoassay for the detection of bovine antibodies to vesicular stomatitis. Am J Vet Res 47: 1507-1512, l986.
26. Yilma T, Breeze RG, Ristow S, Gorham J, Leib SR: A glycoprotein subunit vaccine for vesicular stomatitis. Proc World Assn for Buiatrics (XIV World Congr Dis Cattle) l: 408-413, l986.
27. Yilma T, Mackett M, Rose JK, Moss B: A vaccinia vector vaccine for vesicular stomatitis. Proc World Assn for Buiatrics (XIV World Congr Dis Cattle) l: 402-407, l986.
28. Yilma T: Biotechnology for Livestock Production. In: Mahey B. ed. Virus Vector Vaccines. Food and Agriculture Organization of the United Nations, Rome, Italy. AGA: BIOT/86/32: 2-20, 1986.
29. Leid RW, Suquet CM, Grant RF, Tanigoshi L, Blanchard DB, Yilma T: Taeniaestatin, a cestode proteinase inhibitor with broad host regulatory activity. In: Agabian N, Goodman H, Noguiera N. Molecular Strategies of Parasitic Invasion. UCLA Symposium on Molecular and Cellular Biology, 42: 653-663. New York, Alan R. Liss, 1987.
30. Yilma T, Ristow S, Moss B, Jones L: A novel approach for the production of monoclonal antibodies using infectious vaccinia virus recombinants. Hybridoma 6: 329-335, l987.
31. Yilma T, Anderson K., Brechling K, and Moss B: Expression of an adjuvant gene (BoIFN-gamma) in infectious vaccinia virus recombinants. In: Chanock RM, Giensburg H, Lerner R, Brown F eds. Vaccines 87. Modern Approaches to New Vaccines including Prevention of AIDS. Cold Spring Harbor Laboratory. Cold Spring Harbor, N.Y., pp. 393-396, l987.
32. Osburn BI, Yilma T: Animal Disease Diagnostics and Vaccines. ROC-USA Agricultural Biotechnology Workshop, pp. 64-82, l987.
33. Yilma T: Adjuvant genes for infectious virus recombinant vaccines: Use of lymphokines as adjuvants. Biotechnology U.S.A. 238-246, 1987.
34. Yilma T, Owens S, Adams SD: High levels of interferon in synovial fluid of retrovirus-infected goats. J Interferon Res 8: 45-50, l988.
35. Anderson P K, Fennie H, Yilma T: Enhancement of a secondary antibody response by interferon-gamma treatment at primary immunization. J Immunol 40: 3599-3604, 1988.
36. Grubman M, Mebus C, Dale B, Yamanaka M, Yilma T: Analysis of the polypeptides synthesized in rinderpest virus-infected cells. Virology 163:261-267, 1988.
37. Ristow S, Leendersten L, Gorham J, Yilma T: Identification of a neutralizing epitope shared by bluetongue virus serotypes 2 and 13 . J.Virol. 62: 2502-2504, 1988.
38. Hsu D, Yamanaka M, Miller J, Dale B , Grubman M, Yilma T: Cloning of the fusion gene of rinderpest virus: comparative sequence analysis with other morbilliviruses. Virology 166: 149-153, 1988.
39. Yamanaka M, Hsu D, Dale B, Crisp T, Grubman M, Yilma T: Cloning and sequence analysis of the hemagglutinin gene of the virulent strain of rinderpest virus. Virology 166: 251-253, 1988.
40. Yilma T: Animal Biotechnology. In: The National Academy of Sciences & National Research Council: "Science & Technology for Development: Prospects Entering the 21st Century" pp. 38-40, 1988.
41. Yilma T., Hsu D., Jones L., Owens S., Grubman M., Mebus C., Yamanaka M., Dale B: Protection of cattle against rinderpest with infectious vaccinia virus recombinants expressing the HA or F gene. Science 242:1058-1061,1988.
42. Dale B, Brown R, Kloss, JM, Cordell B, Moore BO, Yilma T: Generation of vaccinia virus-equine influenza A virus recombinants and their use as immunogens in horses. Fifth International Conference on Equine Infectious Diseases, 80-87, 1988.
43. Yilma T: Vaccinia virus as a vector for other antigens. Proc. U.S. Ani. Hlth. Assn 92: 94-99, 1988.
44. ole-MoiYoi OK., Nayar A., Iams K., Musoke AJ, Yilma T: Molecular Aspects of Theileria parva and Approaches to Vaccine Development for Animals. In: Bloom BR, Cerami A eds. Biomedical Science and the Third World: Under the Volcano. Annals of the New York Academy of Sciences 569: 174-182, 1989.
45. Yilma T., Hsu D., Jones L., Owens S., Grubman M., Mebus C., Yamanaka M., Dale B: Expression of rinderpest genes in vaccinia virus Recombinants: Protective immunization of cattle. In: Chanock RM, Giensburg H, Lerner R, Brown F eds. Vaccines 89. Modern Approaches to New Vaccines including
46. Prevention of AIDS. Cold Spring Harbor Laboratory, New York, pp. 393-396,l989.
47. Yilma T, Owens S, Fennie H, Anderson PK: Enhancement of primary and secondary immune responses by interferon-gamma. Adv. Exp. Med. Bio. 251: 145-152, 1989.
48. Yilma T: Prospects for the total eradication of rinderpest. Vaccine 7: 484-485, 1989.
49. Yilma T: A recombinant vaccine for rinderpest. In: Mukherjee, T.K.. ed. Proceedings of the FAO/UNDP Workshop on Biotechnology in Animal Production and Health in Asia and Latin America. Beijing, Oct 9-13, 1989.
50. Limo M, Yilma T: Molecular cloning of the rinderpest virus matrix gene: comparative sequence analysis with other paramyxoviruses. Virology 175: 323-327, 1990.
51. Yilma T: Accomplishments in recombinant vaccines. in Vasil IK ed. Biotechnology: Science, Education, and Commercialization. New York: Elsevier-North Holland, pp 71-77, 1990.
52. McGraw TP, Vowles BR, Carlson JR, Luciw PA, Yilma T, Marx P, Haigwood N, Steimer SK, Gardner MB: Immune response of nonhuman primates infected with SIV and immunogenicity studies of lentivirus vaccine products. In: Chanock RM, Giensburg H, Lerner R, Brown F eds. Vaccines 90. Modern Approaches to New Vaccines including Prevention of AIDS. Cold Spring Harbor Laboratory. Cold Spring Harbor, N.Y., pp. 389-392, 1990.
53. Fox LK, Liggit HD, Corbeil LB, Yilma T: The effect of interferon-gammaintramammary administration on mammary phagocyte function. J. Vet. Med. 37: 28-30, 1990.
54. Yilma T: A modern vaccine for an ancient plague: Rinderpest. Biotechnology 8: 1007-1009, 1990.
55. Chillakuru RA, Ryu DDY, Yilma T: Propagation of recombinant vaccinia virus in hela cells: Adsorption kinetics and replication in batch cultures. Biotechnol. Prog. 7: 85-92, 1991.
56. Yilma T: Genetically engineered viral vaccines. In: Mailu, A. M. et al. eds. Proceedings of the National Conference on Plant and AnimalBiotechnology: Biotechnology in Kenya. Nairobi, pp. 59-66, 1991.
57. Limo MK, Ahmad S, Yilma T: Nucleic acid and monoclonal antibody probes in disease diagnosis. In: Mailu, A. M. et al. eds. Proceedings of the National Conference on Plant and Animal Biotechnology: Biotechnology in Kenya. Nairobi, pp. 103-111, 1991.
58. Giavedoni L, Jones L, Mebus C, Yilma T: A vaccinia virus double recombinant expressing F and H genes protects cattle against rinderpest and causes no pock lesions. Proceedings of the National Academy of SciencesU.S.A. 88: 8011-8015, 1991.
59. Yilma T: The role of biotechnology in tropical diseases. In Williams J, Kocan K, and Gibbs EP, Tropical Veterinary Medicine: Current Issues andPerspectives, Annals of the New York Academy of Sciences, 653: 1-6, June 16, 1991.
60. Yilma T: A vaccinia virus recombinant vaccine for rinderpest. World Animal Review (A Quarterly Journal of the FAO/UN on Animal Health, Production, and Products). 69: 2-6, 1991.
61. Gardner M, Yamamoto J, Marthas M, Miller C, Jennings M, Rosenthal A, Luciw P, Planelles V, Yilma T, Giavedoni L, Ahmad S, Steimer K, Haigwood N, and Pedersen N: SIV and FIV vaccine studies at UC Davis: 1991 Update. Proceedings of the NCVDG, Marco Island, FL. October 15-19, 1991.
62. Yilma T, Jones L, Mebus C, Giavedoni L: A non-pock forming vaccinia virus double recombinant expressing the F and H genes protects cattle against rinderpest. Proc. U.S. Ani. Hlth. Assn, 95th Annual Meeting, 50-58, San Diego, California, 1992.
63. Planelles V, Giavedoni L, Marthas M, Ahmed S, Scandella C, Luciw P, Yilma T, Marx P, Lackner, A, Gardner M, Haigwood N: Vaccine studies with SIVmac1A11 recombinant GP130: lack of protection from SIVmac251 challenge. In: Brown F, Chanock RM, Giensburg H, Lerner R, eds. Vaccines 92. Modern Approaches to New Vaccines including Prevention of AIDS. Cold Spring Harbor Laboratory. Cold Spring Harbor, N.Y., p. 123-129, 1992.
64. Haigwood N, Misher L, Chin SM, Blair M, Planelles V, Scandella C, Steimer K, Gardner M, Yilma T, Hirsch V, Johnson P: Characterization of group specific antibodies in primates: studies with SIV envelope in macaques. J. Med. Primatol., 21: 82-90, 1992.
65. Gardner MB, Yamamoto M, Marthas M, Miller C, Jennings M, Rosenthal A, Luciw P, Planelles V, Yilma T, Giavedoni L, Ahmad S, Steimer K, Haigwood N, and Pedersen N: SIV and FIV Vaccine Studies at UC Davis: 1991 Update. In Liebert, AIDS Research and Human Retroviruses, Volume 8, Number 8, 1495-1498, 1992.
66. Maclachlan NJ, Rossitto PV, Heidner HW, Iezzi LG, Yilma T, DeMaula CD, Osburn BI: Variation amongst the neutralizing epitopes of bluetongue viruses isolated in the United States in 1979-1981, Veterinary Microbiology, 31: 303-316, 1992, Elseveir Science Publishers, 1992.
67. Yilma T: Recombinant Vaccines: Vaccinia Virus Vectored Vaccines. In, Osburn B, Castrucci G, Schore C: New and Emerging Infectious Diseases, Proceedings of the World Association of Veterinary Microbiologists, Immunologists and Specialists in Infectious Diseases (W.A.V.M.I.), University of California, Davis, pgs. 181-187, Sept. 9-12, 1992.
68. Giavedoni L, Jones L, Gardner M, Gibson H, Ng C, Barr P, Yilma T: Vaccinia Virus Recombinants Expressing Chimeric Proteins of Human Immunodeficiency Virus and -Interferon Are Attenuated for Nude Mice. Proceedings of the National Academy of Sciences, USA. 89: 3409-3413, 1992.
69. Yamanaka M, Dale B, Crisp T, Cordell, B., Grubman M, Yilma T: Sequence analysis and editing of the phosphoprotein (P) gene of rinderpest virus. Virology, 190: 553-556, 1992.
70. Giavedoni L, Planelles V, Haigwood N, Ahmad S, Kluge JD, Marthas M,Gardner MB, Luciw P, Yilma T: Immune response of rhesus macaques to recombinant SIVgp130 does not protect from challenge infection. J. Virol,67: 577-583, 1993.
71. Ahmad S, Bassiri M, Banerjee A, Yilma T: Immunological characterization of the VSV nucleocapsid (N) protein expressed by recombinant baculovirus in spodoptera exigua larva: Use of differential diagnosis between vaccinatedand infected animals. Virology, 192: 207-216, 1993.
72. Bassiri M, Ahmad S, Giavedoni L, Jones L, Saliki J.T., Mebus C, Yilma T:Immunological Response of Mice and Cattle to Baculovirus-Expressed F and H proteins of rinderpest virus. J. Virol, 67: 1255-1261, 1993.
73. Ahmad S, Giavedoni L, El-Amad Z, Haigwood N, Kilpatrick J, Scandella C, Marthas M, Gardner M, Luciw P, Yilma T: Immune Response of Rhesus Macaques to Recombinant SIV gp160 Does Not Protect from Challenge Infection. In: Brown F, Chanock RM, Giensburg H, Lerner R, eds. Vaccines 93. Modern Approaches to New Vaccines including Prevention of AIDS. p. 57-62, ColdSpring Harbor Laboratory. Cold Spring Harbor, N.Y., 1993.
74. Jones L, Giavedoni L, Saliki JT, Brown C, Mebus C, Yilma T: Protection of goats against peste des petits ruminants with a vaccinia virus double recombinant expressing the F and H genes of rinderpest virus. Vaccine,11:9, 961-964 , 1993.
75. Yilma T, Giavedoni L, Seliki J, Brown C, Mebus C, Jones L: Protection of goats against peste des petits ruminants by a vaccinia virus double recombinant expressing the F and H genes of rinderpest virus. Proc. U.S. Ani. Hlth. Assn, 96th Annual Meeting, 184-189, Louisville, Kentucky, 1993.
76. Yilma, T: Vaccinia virus recombinant vaccines against rinderpest. In Volume of Recombinant Vaccines: New Vaccinology, Edouard Kurstak, Editor,1994.
77. Ismail T, Ahmad S, D'Souza-Ault M, Bassiri M, Saliki J, Mebus C, Yilma T: Cloning and expression of the nucleocapsid gene of virulent kabete o strain of rinderpest virus in baculovirus: use in differential diagnosis between vaccinated and infected animals. Virology 198: 138-147, 1994.
78. Yilma, T: Recombinant vaccines and rapid diagnostic kits: transfer of technologies to developing countries. In G. P. Talwar, et al, editors, Recombinant and Synthetic Vaccines, Narcosa Publishing, Inc., 1-14, 1994.
79. Yilma, T: Transfer of technologies in molecular biology to developing countries - recombinant vaccines and rapid diagnostic kits for diseases in the developing world. In Biotechnology Research & Development Trends: Science Policy for Development, New York Academy of Sciences, Volume 700, 22-31, 1994.
80. Ismail T, Ahmad S, Saliki J, Mebus C, Yilma T: Differential diagnosis between rinderpest-vaccinated and infected animals using the nucleocapsid protein expressed in baculovirus. Proc. U.S. Ani. Hlth. Assn, 97th Annual Meeting, Las Vegas, Nevada, pages 107-117, 1994.
81. Yilma T: Genetically engineered vaccines for animal viral diseases. Journal of the American Veterinary Medical Association, 204:10, 1606-1615, 1994.
82. Ahmad S, Lohma B, Marthas M, Giavedoni L, El-Amad Z, Haigwood N, Scandella C, Gardner M, Luciw P, and Yilma T: Reduced virus load in rhesus macaques immunized with recombinant gp160 and challenged with simian immunodeficiency virus. AIDS Research and Human Retroviruses, 10:2,195-204,1994.
83. Mitchell WM, Torres J, Johnson PR, Hirsch V, Yilma T, Gardner MB, Robinson WE Jr.: Antibodies to the putative SIV infection-enhancing domain diminish beneficial effects of an SIV gp160 vaccine in rhesus macaques. AIDS Research and Human Retroviruses , 9:1, 27-34, 1994.
84. Ismail T, Yamanaka M, Jeremiah T. Saliki, El-Kholy A, Saliki J, MebusC, and Yilma T: Cloning and expression of the nucleocapsid gene of peste des petits ruminants virus in baculovirus for use in serological diagnosis. Virology, 208, 776-778, 1995.
85. Harrer T, Harrer E, Kalams Spyros, Barbosa P, Trocha A, Johnson R.P, Elkbeik T, Yilma T, Feinberg M, Buchbinder S, Walker B: Identification of a vigorous and broadly directed virus-specific cytotoxic T lymphocyte response in asymptomatic long-term non-progressing HIV-1infection.
86. Yilma T: Vaccinia virus recombinant vaccines for rinderpest. Dev BiolStand. Basel, Karger, 1995, vol 84, pp 201-208.
87. Yilma T: Vaccine technology. Encyclopedia of Molecular Biology and Mol Medicine, 6: 165-171, 1995.
88. de Mattos CC, de Mattos CA, Maclachlan NJ, Giavedoni LD, Yilma T, Osburn BI. Phylogenetic Comparison of the S3 Gene of United States Prototype Strains of Bluetongue Virus with that of Field Isolates from California. J Virol 70(8): 5735-9, 1996.
89. Harrer T, Harrer E, Kalams S, Elbeik T, Staprans S.I., Feinberg M, Cao Y, Ho D, Yilma T, Caliendo A, Johnson R, Buchbinder S, and Walker B: Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable nonprogressing HIV-1 infection. AIDS Res.Hum.Retrov, 12: 585-592, 1996.
90. Giavedoni L,Yilma T: Construction and characterization of replication-competent SIV vectors that express interferon-gamma. J. Virol., 70: 2247-2251, 1996.
91. Yilma T. Sustainable Animal Production in Developing Countries. The Forum Engleberg: Food & Water, A Question of Survival. Engleberg, Switzerland , p. 1-13, 1997.
92. Giavedoni L, Jones L, Ahmad S, Yilma T: SIV expressing IFN-gamma: a safer and more efficacious vaccine for macaques. J. Virol., 70:866-872, 1997.
93. Jones L, Tenorio E, Gorham J, Yilma T. Protective vaccination of ferrets against canine distemper with recom pox virus vaccines expressing the H or F genes of rinderpest virus. Ame. J Vet. Res. 58: 590-3, 1997.
94. Rickie WK, Wakenell PS, Ahmad S, Yilma T, Hirsh DC. Lack of protection against avian cholera by vaccination with recombinant P6-like protein from Pasteurella multocida. Avian Diseases 41: 972-976, 1997.
95. Yamanaka M, Yilma T. Altered plaque formation by recombinant vaccinia virus expressing SIV?nef. J. Virol. 72: 5291-5295, 1998.
96. Araqdaib IE, Wilson WC, Shore CE, Mohammed MEH, Yilma T, Osburn BI. PCR detection of North America and Central African isolates of epizootic hemorrhagic disease virus (EHDV) based on genome segment 10 of EHDV Serotype 1. J Clin Micro 36: 2604-2608, 1998.
97. Hodges JF, Balasurya UBR, Ahmad S, TimoneyPJ, McCollum WH, Yilma T, Maclachlan NJ. Detection of Antibodies to equine arteritus virus by enzyme linked immonosorbant assays utilizing GL, M and N proteins expressed from recombinant baculoviruses. J. Virol. Meth. 76: 127-137,1998.
98. Patterson JB, Scheiflinger F, Manchester M, Yilma T, Oldstone MBA. Structural and functional studies of the measles virus hemagglutinin: Identification of a novel site required for CD46 interaction. Virology 256: 142-151, 1999.
99. Gauduin M-Cl, Clickman RL, Ahmad S. Yilma T, Johnson RP. Characterization of SIV?specific CD4+ T helper proliferatiive responses in macaques immunized with live attenuated SIV. J. Med. Primatology. 28:233-241, 1999.
100. Gauduin M-Cl, Clickman RL, Ahmad S. Yilma T, Johnson RP. Immunization with live attenuated vaccines induces stron type 1 T helper responses and ß?chemokine production. Proc.Natl. Acad. Sci. U.S.A. 96: 14031-14036, 1999.
101. Jones L, Ahmad S, Verardi PH, Chan K, Simon V, Waddell D, and Yilma. T. Increased Safety and Efficacy of Live Attenuated SIV Vaccines by Prevaccination with Recombinant Vaccinia Virus Vaccines. J. Med. Primatology (in press).